Alexandra L. Hanlon mainly focuses on Radiation therapy, Surgery, Prostate cancer, Prostate and Internal medicine. The concepts of her Radiation therapy study are interwoven with issues in Cumulative incidence and Nuclear medicine. Her Surgery research includes themes of Cancer, Breast cancer, Carcinoma and Risk factor.
Her biological study spans a wide range of topics, including Complication, Multivariate analysis, Proportional hazards model and Urology. Alexandra L. Hanlon has researched Prostate in several fields, including Clinical trial, Rectum, Toxicity, Perineural invasion and Cohort. The study incorporates disciplines such as Gastroenterology, Diabetes mellitus and Oncology in addition to Internal medicine.
Her primary areas of study are Radiation therapy, Internal medicine, Prostate cancer, Surgery and Oncology. Her studies deal with areas such as Stage, Carcinoma and Nuclear medicine as well as Radiation therapy. Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.
Her Prostate cancer study integrates concerns from other disciplines, such as Multivariate analysis, Prostate, Gynecology and Urology. The various areas that she examines in her Surgery study include Cancer, Breast cancer and Univariate analysis. Her Metastasis research extends to the thematically linked field of Oncology.
Her primary scientific interests are in Gerontology, Internal medicine, Nursing, Intervention and Clinical psychology. Her research in Internal medicine intersects with topics in Endocrinology and Oncology. Her Oncology research integrates issues from Proportional hazards model, Univariate analysis, Progression-free survival and Performance status.
Performance status is a subfield of Surgery that Alexandra L. Hanlon investigates. Her research in Radiation therapy tackles topics such as Surgical oncology which are related to areas like Prostate cancer. Prostate cancer is the subject of her research, which falls under Cancer.
Alexandra L. Hanlon mostly deals with Gerontology, Internal medicine, Oncology, Cross-sectional study and Odds. Her work deals with themes such as Progression-free survival, Prostate cancer, Propensity score matching, Univariate analysis and Radiation therapy, which intersect with Oncology. Alexandra L. Hanlon works mostly in the field of Prostate cancer, limiting it down to topics relating to Intensity-modulated radiation therapy and, in certain cases, Stereotactic body radiation therapy.
Her research in Radiation therapy is mostly focused on Post operative radiotherapy. Her T-stage research entails a greater understanding of Surgery. Her Surgery research is multidisciplinary, relying on both Androgen deprivation therapy and Genitourinary system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089
T.E. Le Voyer;E.R. Sigurdson;A.L. Hanlon;R.J. Mayer.
Journal of Clinical Oncology (2003)
The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World Literature
Sam N. Chawla;Paul L. Crispen;Alexandra L. Hanlon;Richard E. Greenberg.
The Journal of Urology (2006)
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions
Gerald E Hanks;Alexandra L Hanlon;Timothy E Schultheiss;Wayne H Pinover.
International Journal of Radiation Oncology Biology Physics (1998)
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
Adam C. Berger;Elin R. Sigurdson;Thomas LeVoyer;Alexandra Hanlon.
Journal of Clinical Oncology (2005)
Late GI and GU complications in the treatment of prostate cancer
Timothy E. Schultheiss;W.Robert Lee;Margie A. Hunt;Alexandra L. Hanlon.
International Journal of Radiation Oncology Biology Physics (1997)
CPAP, Weight Loss, or Both for Obstructive Sleep Apnea
Julio A. Chirinos;Indira Gurubhagavatula;Karen Teff;Daniel J. Rader.
The New England Journal of Medicine (2014)
PATIENTS WITH EARLY STAGE INVASIVE CANCER WITH CLOSE OR POSITIVE MARGINS TREATED WITH CONSERVATIVE SURGERY AND RADIATION HAVE AN INCREASED RISK OF BREAST RECURRENCE THAT IS DELAYED BY ADJUVANT SYSTEMIC THERAPY
Gary Freedman;Barbara Fowble;Alexandra Hanlon;Nicos Nicolaou.
International Journal of Radiation Oncology Biology Physics (1999)
Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection.
Natalie E. Joseph;Elin R. Sigurdson;Alexandra L. Hanlon;Hao Wang.
Annals of Surgical Oncology (2003)
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
Alan Pollack;Alexandra L. Hanlon;Eric M. Horwitz;Steven J. Feigenberg.
International Journal of Radiation Oncology Biology Physics (2006)
Dose response in prostate cancer with 8-12 years' follow-up.
Gerald E Hanks;Alexandra L Hanlon;Barry Epstein;Eric M Horwitz.
International Journal of Radiation Oncology Biology Physics (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: